Manuscripts
Showing 1533 manuscripts.
Intention-to-treat vs. on-treatment analyses of clinical trial data: experience from a study of pyrimethamine in the primary prophylaxis of toxoplasmosis in HIV-infected patients. ANRS 005/ACTG 154 trial group
Citation
Genevieve Chene, Philippe Morlat, Catherine Leport, Richard Hafner, L. Dequae, I. Charreau, Jean-Pierre Aboulker, Benjamin J. Luft, Jean Aubertin, Jean-Louis Vilde, Roger Salamon. Intention-to-treat vs. on-treatment analyses of clinical trial data: experience from a study of pyrimethamine in the primary prophylaxis of toxoplasmosis in HIV-infected patients. ANRS 005/ACTG 154 trial group. Controlled Clinical Trials. 1998. 19: 233-48.Year
1998
Journal
Controlled Clinical Trials
Safety of the Maternal-Infant Zidovudine Regimen Utilized in the Pediatric AIDS Clinical Trial Group 076 Study
Citation
Rhoda S. Sperling, David E. Shapiro, George D. McSherry, Paula Britto, Bethann Cunningham-Schrader, Mary Culnane, Robert W. Coombs, Gwendolyn B. Scott, Russell B. Van Dyke, William T. Shearer, Eleanor Jimenez, Clemente Diaz, Duane Harrison, Jean-Francois Delfraissy. Safety of the Maternal-Infant Zidovudine Regimen Utilized in the Pediatric AIDS Clinical Trial Group 076 Study. AIDS. 1998. 12: 1805-13.Year
1998
Journal
AIDS
Safety and Immunogenicity of HIV Recombinant Envelope Vaccines in HIV-infected Infants and Children
Citation
JS Lambert, J McNamara, SL Katz, T Fenton, MH Kang, TC VanCott, R Livingston, E Hawkins, J Moye, W Borkowsky, D Johnson, R Yogev, AM Duliege, Donald P. Francis, Anne A. Gershon, Diane W. Wara, Natasha L. Martin, Myron Levin, George D. McSherry, Gale Smith. Safety and Immunogenicity of HIV Recombinant Envelope Vaccines in HIV-infected Infants and Children. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 1998. 19: 451-61.Year
1998
Journal
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology
The extent of non-adherence in a large clinical trial using plasma dideoxynucleoside concentrations as a marker
Citation
Helen Kastrissios, J. R. Suarez, Scott M. Hammer, David Katzenstein, Terrence F. Blaschke. The extent of non-adherence in a large clinical trial using plasma dideoxynucleoside concentrations as a marker. AIDS. 1998. 12: 2305-11.Year
1998
Journal
AIDS
Effect of the statistical significance of results on the time to completion and publication of randomized efficacy trials
Citation
John P.A. Ioannidis. Effect of the statistical significance of results on the time to completion and publication of randomized efficacy trials. The Journal of the American Medical Association. 1998. 279: 281-6.Year
1998
Journal
The Journal of the American Medical Association
Attempting to Enhance the Enrollment of Adolescents into AIDS Clinical Trials: The Design of ACTG Protocol 220
Citation
Lawrence D'Angelo, Jane C. Lindsey, Bonnie Zimmer, Mary Culnane, Donna Futterman. Attempting to Enhance the Enrollment of Adolescents into AIDS Clinical Trials: The Design of ACTG Protocol 220. AIDS Patient Care and STDs. 1998. 12: 853-9.Year
1998
Journal
AIDS Patient Care and STDs
Randomized Comparative Trial of Stavudine (d4T) versus Zidovudine (ZDV, AZT) in Children with Human Immunodeficiency Virus Infection
Citation
Mark W. Kline, Russell B. Van Dyke, Jane C. Lindsey, Meg Gwynne, Margaret Gwynne, Mary Culnane, Ross E. Mckinney, Sharon Nichols, Wendy G. Mitchell, Ram Yogev, Nancy Hutcheon. Randomized Comparative Trial of Stavudine (d4T) versus Zidovudine (ZDV, AZT) in Children with Human Immunodeficiency Virus Infection. Pediatrics. 1998. 101: 214-220.Year
1998
Journal
Pediatrics
Pharmacokinetics of Nevirapine in Human Immunodeficiency Virus type 1- Infected Pregnant Women and Their Neonates.
Citation
Mirochnick M, Fenton T, Gagnier P, Pav J, Gwynne M, Siminski S, Sperling RS, Beckerman K, Jimenez E, Yogev R, Spector SA, Sullivan JL. Pharmacokinetics of Nevirapine in Human Immunodeficiency Virus type 1- Infected Pregnant Women and Their Neonates.. Journal of Infectious Diseases. 1998. 178: 368-74.Year
1998
Journal
Journal of Infectious Diseases
A Phase I Safety and Pharmacokinetics Study of Micronized Atovaquone in Human Immunodeficiency Virus-infected Infants and Children
Citation
Walter T. Hughes, Alejandro Dorenbaum, Ram Yogev, B. Beauchamp, Jing Xu, James McNamara, John ( Jack ) Moye, Lynette Purdue, Russell B. Van Dyke, Martha Rogers, Brian M. Sadler. A Phase I Safety and Pharmacokinetics Study of Micronized Atovaquone in Human Immunodeficiency Virus-infected Infants and Children. Antimicrobial Agents and Chemotherapy. 1998. 42: 1315-18.Year
1998
Journal
Antimicrobial Agents and Chemotherapy
Correspondence (Reply): Safety and Pharmocokinetics Of Hyperimmune Anti-HIV Immunoglobulin (HIVIG) Administered To HIV-Infected Pregnant Women and Their Newborns
Citation
Lambert J, Mofenson LM, Moye J. Correspondence (Reply): Safety and Pharmocokinetics Of Hyperimmune Anti-HIV Immunoglobulin (HIVIG) Administered To HIV-Infected Pregnant Women and Their Newborns. Journal of Infectious Diseases. 1998. 178: 598-99.Year
1998
Journal
Journal of Infectious Diseases